.FDA denies psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Approve MDMA Therapy, Seeking Additional Research Study The The Big Apple TimesFDA Refuses Ecstasy-Based Medicine The Exchange JournalFDA rejects to permit unfamiliar MDMA therapy to manage PTSD, along with request for additional litigation information CNNFDA declines to begin with psychedelic to handle post-traumatic stress disorder, requiring additional research study The Washington Article.